Chronic and Heavy Drinking, Nutrition Status, and Progression of Liver Injury Negatively Affect the Mortality Risk in

Aishwarya Thakurdesai1,2, Anjali Kumari1,2, Henry Shay1,2

  • 1Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Louisville, Louisville, KY 40202, USA.

Journal of Clinical Medicine
|September 13, 2025
PubMed

Insights

Alcohol-associated hepatitis (AH) progression and mortality are worsened by heavy alcohol consumption and poor nutrition. Routine assessment of alcohol intake and nutritional status can identify high-risk patients for improved AH treatment and outcomes.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Alcohol-associated hepatitis (AH) is a severe form of alcohol-associated liver disease (ALD) with high mortality.
  • Current survival prediction for AH primarily relies on static scores like the Age-Bilirubin-INR-Creatinine (ABIC) score.
  • The influence of drinking patterns and nutritional status on AH progression and mortality requires further investigation.

Purpose of the Study:

  • To evaluate the impact of alcohol drinking patterns and nutritional status on AH progression and mortality.
  • To identify key factors influencing severity and survival in patients with AH.

Main Methods:

  • Sixty-one adult AH patients were stratified by MELD score (non-severe vs. severe) and ABIC risk categories.
  • Data collected included demographics, nutritional status (CONUT score), alcohol consumption (lifetime and recent), and clinical/laboratory measures.
  • Statistical analyses correlated drinking patterns and nutritional status with AH severity and mortality predictors.

Main Results:

  • A significant positive correlation was found between ABIC score and lifetime drinking history (LTDH) in all AH patients and severe AH.
  • AST:ALT ratios, a marker of liver injury, were associated with LTDH, AUDIT score, and CONUT score, particularly in intermediate mortality risk patients.
  • Severe AH showed rapid progression even with initially low mortality risk scores.

Conclusions:

  • Chronic and recent heavy alcohol consumption, along with poor nutrition, significantly worsen AH severity and increase mortality risk.
  • Integrating alcohol intake and nutritional assessments into routine clinical practice can help identify high-risk AH patients.
  • Early identification and intervention based on alcohol consumption and nutritional status may improve treatment outcomes and prognosis for AH patients.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
215
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
257
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
670
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
557